N-[3-(difluoromethyl)-1-[4-[[5-[4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-1-methylindazol-7-yl]pyrazol-1-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-5-(4-oxa-7-azaspiro[2.5]octan-7-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide

C46H52F2N14O4 — CID 175761322

IUPACN-[3-(difluoromethyl)-1-[4-[[5-[4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-1-methylindazol-7-yl]pyrazol-1-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-5-(4-oxa-7-azaspiro[2.5]octan-7-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
SMILESCn1nc(N2CCC(=O)NC2=O)c2cccc(-c3cnn(C4CC5CN(CC6CCC(n7cc(NC(=O)c8cnn9ccc(N%10CCOC%11(CC%11)C%10)nc89)c(C(F)F)n7)CC6)CC5C4)c3)c21
InChIInChI=1S/C46H52F2N14O4/c1-56-40-33(3-2-4-34(40)43(55-56)59-13-10-38(63)53-45(59)65)30-19-49-61(24-30)32-17-28-22-57(23-29(28)18-32)21-27-5-7-31(8-6-27)62-25-36(39(54-62)41(47)48)51-44(64)35-20-50-60-14-9-37(52-42(35)60)58-15-16-66-46(26-58)11-12-46/h2-4,9,14,19-20,24-25,27-29,31-32,41H,5-8,10-13,15-18,21-23,26H2,1H3,(H,51,64)(H,53,63,65)
InChIKeyDVCGYDRTZFDJRI-UHFFFAOYSA-N
MW903.01 g/mol
LogP6.00
Rot. Bonds10

About N-[3-(difluoromethyl)-1-[4-[[5-[4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-1-methylindazol-7-yl]pyrazol-1-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-5-(4-oxa-7-azaspiro[2.5]octan-7-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide

N-[3-(difluoromethyl)-1-[4-[[5-[4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-1-methylindazol-7-yl]pyrazol-1-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-5-(4-oxa-7-azaspiro[2.5]octan-7-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide (PubChem CID 175761322) has the molecular formula C46H52F2N14O4 and a molecular weight of 903.01 g/mol. Its IUPAC name is N-[3-(difluoromethyl)-1-[4-[[5-[4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-1-methylindazol-7-yl]pyrazol-1-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-5-(4-oxa-7-azaspiro[2.5]octan-7-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide.

Molecular Properties

Compound NameN-[3-(difluoromethyl)-1-[4-[[5-[4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-1-methylindazol-7-yl]pyrazol-1-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-5-(4-oxa-7-azaspiro[2.5]octan-7-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
PubChem CID175761322
Molecular FormulaC46H52F2N14O4
Molecular Weight903.01 g/mol
Exact Mass902.43
IUPAC NameN-[3-(difluoromethyl)-1-[4-[[5-[4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-1-methylindazol-7-yl]pyrazol-1-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-5-(4-oxa-7-azaspiro[2.5]octan-7-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
SMILESCn1nc(N2CCC(=O)NC2=O)c2cccc(-c3cnn(C4CC5CN(CC6CCC(n7cc(NC(=O)c8cnn9ccc(N%10CCOC%11(CC%11)C%10)nc89)c(C(F)F)n7)CC6)CC5C4)c3)c21
InChIInChI=1S/C46H52F2N14O4/c1-56-40-33(3-2-4-34(40)43(55-56)59-13-10-38(63)53-45(59)65)30-19-49-61(24-30)32-17-28-22-57(23-29(28)18-32)21-27-5-7-31(8-6-27)62-25-36(39(54-62)41(47)48)51-44(64)35-20-50-60-14-9-37(52-42(35)60)58-15-16-66-46(26-58)11-12-46/h2-4,9,14,19-20,24-25,27-29,31-32,41H,5-8,10-13,15-18,21-23,26H2,1H3,(H,51,64)(H,53,63,65)
InChIKeyDVCGYDRTZFDJRI-UHFFFAOYSA-N
XLogP6.00
TPSA177.87 Ų
H-Bond Donors2
H-Bond Acceptors15
Rotatable Bonds10
Heavy Atoms66
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500903.01
LogP ≤ 56.00
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1015

Analyze N-[3-(difluoromethyl)-1-[4-[[5-[4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-1-methylindazol-7-yl]pyrazol-1-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-5-(4-oxa-7-azaspiro[2.5]octan-7-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[3-(difluoromethyl)-1-[4-[[5-[4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-1-methylindazol-7-yl]pyrazol-1-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-5-(4-oxa-7-azaspiro[2.5]octan-7-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide?
The IUPAC name of N-[3-(difluoromethyl)-1-[4-[[5-[4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-1-methylindazol-7-yl]pyrazol-1-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-5-(4-oxa-7-azaspiro[2.5]octan-7-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide (CID 175761322) is N-[3-(difluoromethyl)-1-[4-[[5-[4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-1-methylindazol-7-yl]pyrazol-1-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-5-(4-oxa-7-azaspiro[2.5]octan-7-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide.
What is the SMILES notation for N-[3-(difluoromethyl)-1-[4-[[5-[4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-1-methylindazol-7-yl]pyrazol-1-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-5-(4-oxa-7-azaspiro[2.5]octan-7-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide?
The canonical SMILES for N-[3-(difluoromethyl)-1-[4-[[5-[4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-1-methylindazol-7-yl]pyrazol-1-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-5-(4-oxa-7-azaspiro[2.5]octan-7-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide is Cn1nc(N2CCC(=O)NC2=O)c2cccc(-c3cnn(C4CC5CN(CC6CCC(n7cc(NC(=O)c8cnn9ccc(N%10CCOC%11(CC%11)C%10)nc89)c(C(F)F)n7)CC6)CC5C4)c3)c21.
What is the InChIKey of N-[3-(difluoromethyl)-1-[4-[[5-[4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-1-methylindazol-7-yl]pyrazol-1-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-5-(4-oxa-7-azaspiro[2.5]octan-7-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide?
The InChIKey is DVCGYDRTZFDJRI-UHFFFAOYSA-N. The full InChI is InChI=1S/C46H52F2N14O4/c1-56-40-33(3-2-4-34(40)43(55-56)59-13-10-38(63)53-45(59)65)30-19-49-61(24-30)32-17-28-22-57(23-29(28)18-32)21-27-5-7-31(8-6-27)62-25-36(39(54-62)41(47)48)51-44(64)35-20-50-60-14-9-37(52-42(35)60)58-15-16-66-46(26-58)11-12-46/h2-4,9,14,19-20,24-25,27-29,31-32,41H,5-8,10-13,15-18,21-23,26H2,1H3,(H,51,64)(H,53,63,65).
What are the key properties of N-[3-(difluoromethyl)-1-[4-[[5-[4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-1-methylindazol-7-yl]pyrazol-1-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-5-(4-oxa-7-azaspiro[2.5]octan-7-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide?
N-[3-(difluoromethyl)-1-[4-[[5-[4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-1-methylindazol-7-yl]pyrazol-1-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-5-(4-oxa-7-azaspiro[2.5]octan-7-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide has a molecular weight of 903.01 g/mol, XLogP of 6.00, 10 rotatable bonds, 2 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-(difluoromethyl)-1-[4-[[5-[4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-1-methylindazol-7-yl]pyrazol-1-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-5-(4-oxa-7-azaspiro[2.5]octan-7-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide is sourced from PubChem (CID 175761322), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).